Predictors of CD4 health and viral suppression outcomes for formerly homeless people living with HIV/AIDS in scattered site supportive housing

被引:25
|
作者
Bowen, Elizabeth A. [1 ]
Canfield, James [2 ]
Moore, Suzanne [3 ]
Hines, Midge [3 ]
Hartke, Brent [3 ]
Rademacher, Chrissy [3 ]
机构
[1] SUNY Buffalo, Sch Social Work, 685 Baldy Hall, Buffalo, NY 14260 USA
[2] Univ Cincinnati, Sch Social Work, Coll Allied Hlth Sci, Cincinnati, OH USA
[3] Caracole Inc, Cincinnati, OH USA
关键词
Homeless; social determinants of health; shelter plus care; supportive housing; viral suppression; ANTIRETROVIRAL THERAPY USE; FOOD INSECURITY; MEDICAL-CARE; LOS-ANGELES; DRUG-USERS; HIV; INDIVIDUALS; DISPARITIES; ADULTS; LOAD;
D O I
10.1080/09540121.2017.1307920
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Stable housing is key to improving health outcomes for people living with HIV/AIDS. Though many formerly homeless HIV positive individuals reside in supportive housing, little research has examined biometric HIV health outcomes for residents of these programs. Through a community-based research partnership, this study analyzed secondary data from a Shelter Plus Care supportive housing program in Cincinnati, Ohio to examine the likelihood of participants achieving a healthy CD4 count (>500cells/mm(3)) and viral suppression (viral load <200copies/mL) while in supportive housing and to identify participant characteristics associated with these outcomes. The study sample was 86 participants who entered the program between 2008 and 2016, including 50 current residents and 36 exited participants. Participants' average length of stay in Shelter Plus Care was 35.2 months (range 3.2-108.1 months) during the study period. Bivariate analysis indicated statistically significant improvements on both outcome variables, with 45% of participants achieving a healthy CD4 count and 79% achieving viral suppression by program exit or most recent time point. Participants who had health insurance at intake and who had never been incarcerated were more likely to achieve viral suppression, and longer length of stay in the program was also positively associated with viral suppression. These results add to the literature on the relationship between housing conditions and HIV health outcomes by demonstrating that residence in supportive housing is associated with improvements in CD4 count and viral load for a sample of formerly homeless persons living with HIV/AIDS, two-thirds of whom had co-occurring physical health, mental health, or substance abuse problems. Further research collaborations should expand on these findings to examine the service packages that are associated with optimal HIV health outcomes for supportive housing residents.
引用
收藏
页码:1458 / 1462
页数:5
相关论文
共 50 条
  • [41] SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV
    Vergori, Alessandra
    Cozzi-Lepri, Alessandro
    Tavelli, Alessandro
    Mazzotta, Valentina
    Azzini, Anna Maria
    Gagliardini, Roberta
    Mastrorosa, Ilaria
    Latini, Alessandra
    Pellicano, Giovanni
    Taramasso, Lucia
    Ceccherini-Silberstein, Francesca
    Giannella, Maddalena
    Tacconelli, Evelina
    Marchetti, Giulia
    Monforte, Antonella d'Arminio
    Antinori, Andrea
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 144
  • [42] CD4/CD8 ratio and CD8+T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis
    Ron, Raquel
    Martinez-Sanz, Javier
    Herrera, Sabina
    Ramos-Ruperto, Luis
    Diez, Alejandro
    Sainz, Talia
    alvarez-Diaz, Noelia
    Correa-Perez, Andrea
    Muriel, Alfonso
    Lopez-Alcalde, Jesus
    Perez-Molina, Jose A.
    Moreno, Santiago
    Serrano-Villar, Sergio
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV
    Win Min Han
    Tanakorn Apornpong
    Stephen J. Kerr
    Akarin Hiransuthikul
    Sivaporn Gatechompol
    Tanya Do
    Kiat Ruxrungtham
    Anchalee Avihingsanon
    AIDS Research and Therapy, 15
  • [44] CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV
    Han, Win Min
    Apornpong, Tanakorn
    Kerr, Stephen J.
    Hiransuthikul, Akarin
    Gatechompol, Sivaporn
    Do, Tanya
    Ruxrungtham, Kiat
    Avihingsanon, Anchalee
    AIDS RESEARCH AND THERAPY, 2018, 15
  • [45] Artificial Intelligence and Machine Learning Based Prediction of Viral Load and CD4 Status of People Living with HIV (PLWH) on Anti-Retroviral Treatment in Gedeo Zone Public Hospitals
    Seboka, Binyam Tariku
    Yehualashet, Delelegn Emwodew
    Tesfa, Getanew Aschalew
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 435 - 451
  • [46] Liver function tests, CD4 + counts, and viral load among people living with HIV on dolutegravir compared to efavirenz-based cART; a comparative cross-sectional study
    Mengistu, Enyew Fenta
    Malik, Tabarak
    Molla, Meseret Derbew
    Adugna, Adane
    Jemal, Mohammed
    HELIYON, 2024, 10 (12)
  • [47] CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis (vol 15, 1343124, 2024)
    Ron, Raquel
    Martinez-Sanz, Javier
    Herrera, Sabina
    Ramos-Ruperto, Luis
    Diez-Vidal, Alejandro
    Sainz, Talia
    Alvarez-Diaz, Noelia
    Correa-Perez, Andrea
    Muriel, Alfonso
    Lopez-Alcalde, Jesus
    Perez-Molina, Jose A.
    Moreno, Santiago
    Serrano-Villar, Sergio
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/μL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa
    Fatti, Geoffrey
    Grimwood, Ashraf
    Nachega, Jean B.
    Nelson, Jenna A.
    LaSorda, Kelsea
    van Zyl, Gert
    Grobbelaar, Nelis
    Ayles, Helen
    Hayes, Richard
    Beyers, Nulda
    Fidler, Sarah
    Bock, Peter
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (03) : 395 - 403
  • [49] High rates of virological suppression after 24 weeks of tenofovir alafenamide/emtricitabine/bictegravir (BIC/FTC/TAF) in people living with HIV (PLWHIV) starting antiretroviral therapy with &lt;200 CD4 cell count
    Perez-Valero, I.
    Corona Mata, D.
    Camacho Espejo, A.
    Roca-Oporto, C.
    Tomas, C.
    Cabello, N.
    Cervero Jimenez, M.
    Navarro, M.
    Rivero-Juarez, A.
    Rivero Roman, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 56 - 57
  • [50] CD4+T-cell count below 200 cells/mm3 is associated with worse COVID-19 outcomes among people living with HIV regardless of virological suppression
    Nomah, D. K.
    Reyes-Uruena, J.
    Diaz, Y.
    Moreno, S.
    Aceiton, J.
    Bruguera, A.
    Vivanco-Hidalgo, R. M.
    Llibre, J. M.
    Domingo, P.
    Falco, V.
    Imaz, A.
    Cortes, C.
    Force, L.
    Letang, E.
    Vilaro, I.
    Casabona, J.
    Miro, J. M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 : 12 - 13